Your browser doesn't support javascript.
loading
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
Zhang, Shenghong; Chen, Baili; Wang, Bangmao; Chen, Hong; Li, Yan; Cao, Qian; Zhong, Jie; Shieh, Ming-Jium; Ran, Zhihua; Tang, Tongyu; Yang, Ming; Xu, Beibei; Wang, Qiang; Liu, Yunjie; Ma, Lijia; Wang, Xiaolin; Zhang, Nan; Zhang, Su; Guo, Wenyu; Huang, Liang; Schreiber, Stefan; Chen, Minhu.
Afiliação
  • Zhang S; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen B; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wang B; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Chen H; Department of Gastroenterology, Affiliated ZhongDa Hospital, School of Medicine Southeast University, Nanjing, China.
  • Li Y; Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Cao Q; Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
  • Zhong J; Department of Gastroenterology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Shieh MJ; Department of Oncology, National Taiwan University Hospital & College of Medicine, Taipei, China.
  • Ran Z; Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Tang T; Department of Gastroenterology, Bethune First Affiliated Hospital of Jilin University, Changchun, China.
  • Yang M; I-Mab Biopharma (Shanghai), Shanghai, China.
  • Xu B; I-Mab Biopharma (Shanghai), Shanghai, China.
  • Wang Q; I-Mab Biopharma (Shanghai), Shanghai, China.
  • Liu Y; I-Mab Biopharma (Shanghai), Shanghai, China.
  • Ma L; I-Mab Biopharma (Shanghai), Shanghai, China.
  • Wang X; I-Mab Biopharma (Hangzhou), Hangzhou, China.
  • Zhang N; I-Mab Biopharma (Hangzhou), Hangzhou, China.
  • Zhang S; I-Mab Biopharma (Hangzhou), Hangzhou, China.
  • Guo W; I-Mab Biopharma (Hangzhou), Hangzhou, China.
  • Huang L; I-Mab Biopharma (Hangzhou), Hangzhou, China.
  • Schreiber S; Department of Medicine I, University Hospital Schleswig Holstein, Kiel University, Kiel, Germany.
  • Chen M; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
JAMA ; 329(9): 725-734, 2023 03 07.
Article em En | MEDLINE | ID: mdl-36881032
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Colite Ulcerativa / Quimioterapia de Indução Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Colite Ulcerativa / Quimioterapia de Indução Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article